Biological Effects of Novel Synthetic Guanidine Derivatives Targeting Leishmania (Viannia) braziliensis
Molecules · 2026
DOI: 10.3390/molecules31040629 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Geovane Dias-Lopes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ciências Biomédicas e Saúde, Instituto de Biologia Roberto Alcântara Gomes, Universidade do Estado do Rio de Janeiro, Rua Arízio Gome…. Hauptthemen laut MEDLINE: Leishmania braziliensis, Antiprotozoal Agents, Guanidine. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Leishmaniasis remains an important neglected tropical disease, and current treatments are limited by toxicity, resistance, and low bioavailability. In this study, novel guanidine derivatives were evaluated through an integrated approach, combining in silico physicochemical profiling with in vitro biological assays using Leishmania (Viannia) braziliensis, the etiological agent of American Tegumentary Leishmaniasis (ATL). Most compounds exhibited favorable drug-like properties, though variations in lipophilicity and solubility influenced biological performance. Among the tested molecules, FURL-G5 emerged as the most promising candidate, showing potent activity against promastigote forms and low cytotoxicity in murine macrophages, resulting in high selectivity indices (SI > 10), comparable to those of LQOF-G1, a compound with previously established leishmanicidal effects. These compounds were also tested on intracellular amastigotes, drastically reducing the infection rate of macrophages. The integration of an in silico approach and biological validation enabled rational compound prioritization and supports the early-stage development of these scaffolds. Overall, this study reinforces the potential of guanidine-based compounds as leads for innovative ATL drug discovery and demonstrates the value of multidisciplinary strategies for identifying selective and safe therapeutic candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Ciências Biomédicas e Saúde, Instituto de Biologia Roberto Alcântara Gomes, Universidade do Estado do Rio de Janeiro, Rua Arízio Gomes da Costa 186-Jardim Flamboyant, Cabo Frio 28905-320, RJ, Brazil.
- Laboratório de Biologia Molecular e Doenças Endêmicas, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Avenida Brazil 4365-Manguinhos, Rio de Janeiro 21040-900, RJ, Brazil.
- Laboratório de Química Orgânica Fina, Departamento de Química e Bioquímica, Escola de Ciências e Tecnologia, Universidade Estadual Paulista, Rua Roberto Simonsen, 305-Centro Educacional, Presidente Prudente 19060-080, S…
- Centro de Desenvolvimento Tecnológico em Saúde, Fundação Oswaldo Cruz, Avenida Brazil, 4365-Manguinhos, Rio de Janeiro 21040-900, RJ, Brazil.
- Laboratório de Pesquisa Pré-Clínica, Universidade Iguaçu, Avenida Abílio Augusto Távora 2134, Dom Rodrigo, Nova Iguaçu 26260-045, RJ, Brazil.
- Mass Spectrometry Centre, Faculty of Chemistry, University of Vienna, Währinger Straße 38, A-1090 Vienna, Austria.
ORCID-Profile: Geovane Dias-Lopes, Luana Ribeiro Dos Anjos, Sara Maria Xavier da Cruz, Cauã Dias Abrão, Franklin Souza-Silva, Eduardo Rene Perez González, Carlos Roberto Alves
Förderung
- National Council for Scientific and Technological Development
- Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeicoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico—Brazil
- Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro—Brazil
- Fundação de Amparo à Pesquisa do Estado de São Paulo—Brazil
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brazil
Zitieren
APA
Dias-Lopes, G., Dos Anjos, L. R., Cruz, S. M. X. D., Abrão, C. D., Gonçalves, M. E. P., Souza-Silva, F., Fabisikova, A., González, E. R. P., & Alves, C. R. (2026). Biological Effects of Novel Synthetic Guanidine Derivatives Targeting Leishmania (Viannia) braziliensis. Molecules. https://doi.org/10.3390/molecules31040629
Vancouver
Dias-Lopes G, Dos Anjos LR, Cruz SMXD, Abrão CD, Gonçalves MEP, Souza-Silva F, et al. Biological Effects of Novel Synthetic Guanidine Derivatives Targeting Leishmania (Viannia) braziliensis. Molecules. 2026. doi:10.3390/molecules31040629
BibTeX
@article{DiasLopes2026,
author = {Dias-Lopes, Geovane and Dos Anjos, Luana Ribeiro and Cruz, Sara Maria Xavier da and Abrão, Cauã Dias and Gonçalves, Maria Eduarda Pinto and Souza-Silva, Franklin and Fabisikova, Anna and González, Eduardo Rene Perez and Alves, Carlos Roberto},
title = {Biological Effects of Novel Synthetic Guanidine Derivatives Targeting Leishmania (Viannia) braziliensis},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31040629}
}
EUVIMED